| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 68.007 | 71.076 | 75.276 | 148.034 | 151.675 | 174.336 | 170.656 | 170.539 | 188.698 | 239.117 |
| Total Income - EUR | 68.011 | 71.076 | 75.276 | 148.035 | 151.676 | 174.338 | 170.657 | 170.540 | 188.700 | 239.120 |
| Total Expenses - EUR | 53.576 | 56.394 | 63.689 | 101.631 | 106.206 | 103.060 | 102.824 | 110.593 | 129.316 | 152.728 |
| Gross Profit/Loss - EUR | 14.435 | 14.683 | 11.587 | 46.404 | 45.471 | 71.278 | 67.833 | 59.947 | 59.384 | 86.391 |
| Net Profit/Loss - EUR | 11.884 | 13.972 | 10.834 | 44.923 | 43.955 | 69.648 | 66.126 | 58.242 | 57.497 | 79.361 |
| Employees | 3 | 4 | 4 | 3 | 4 | 3 | 3 | 4 | 5 | 5 |
Check the financial reports for the company - Dr. Ilyes Stelian Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 5.456 | 5.984 | 7.809 | 44.849 | 91.153 | 130.108 | 144.924 |
| Current Assets | 27.948 | 34.995 | 27.243 | 68.972 | 98.598 | 147.771 | 32.445 | 16.114 | 27.542 | 28.723 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.598 | 4.990 | 8.981 | 12.052 | 97.337 | 14.456 | 28.585 | 9.797 | 16.918 | 14.623 |
| Cash | 22.350 | 30.005 | 18.262 | 56.919 | 1.261 | 133.315 | 3.860 | 6.317 | 10.624 | 14.101 |
| Shareholders Funds | 23.535 | 14.026 | 24.622 | 69.094 | 98.488 | 145.701 | 66.174 | 58.291 | 115.611 | 99.513 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.413 | 20.970 | 2.620 | 5.362 | 6.094 | 9.879 | 11.120 | 48.976 | 42.039 | 74.134 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Ilyes Stelian Srl